Mucocutaneous Leishmaniasis
What is Mucocutaneous Leishmaniasis?
Mucocutaneous leishmaniasis is a parasitic infection caused by Leishmania parasites. These parasites spread through the bite of infected sandflies. The disease starts with skin ulcers at the bite site.
Over time, the infection can spread to mucous membranes in your nose, mouth, and throat. This spread typically happens months or even years after the initial skin lesion appears. The condition causes tissue damage and can lead to serious disfigurement if left untreated.
This form of leishmaniasis is most common in parts of Central and South America. It affects people who live in or travel to areas where infected sandflies are present. Early detection and treatment help prevent the spread from skin to mucous membranes.
Symptoms
- Skin sores or ulcers that develop at sandfly bite sites
- Lesions that do not heal within a few weeks
- Sores in the nose that cause stuffiness or bleeding
- Ulcers in the mouth or on the lips
- Difficulty breathing through the nose
- Difficulty swallowing or painful swallowing
- Nasal cartilage destruction leading to saddle nose deformity
- Voice changes or hoarseness
- Tissue destruction in the throat or palate
- Scarring and disfigurement of facial features
Some people have only skin lesions for months or years before mucous membrane involvement occurs. Early skin sores may be painless and easily overlooked.
Concerned about Mucocutaneous Leishmaniasis? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Mucocutaneous leishmaniasis happens when Leishmania parasites enter your body through a sandfly bite. The sandfly picks up the parasite by biting infected animals or people. Certain Leishmania species are more likely to cause the mucocutaneous form, particularly L. braziliensis.
Risk factors include living in or traveling to endemic areas in Central and South America. Working outdoors in forested or rural areas increases your exposure to sandflies. People with weakened immune systems may have more severe infections. Delayed treatment of initial skin lesions raises the risk of spread to mucous membranes.
How it's diagnosed
Doctors diagnose mucocutaneous leishmaniasis through a combination of clinical examination and laboratory tests. They look for characteristic skin lesions and mucous membrane damage. A travel history to endemic areas helps support the diagnosis.
Blood tests can detect antibodies against Leishmania parasites, such as Leishmania Ab IgG. Tissue samples from lesions may be examined under a microscope to identify parasites. Specialized testing is typically required for definitive diagnosis. Talk to a doctor if you have unexplained skin sores or mucous membrane lesions, especially after travel to affected regions.
Treatment options
- Antiparasitic medications such as liposomal amphotericin B or pentavalent antimony compounds
- Miltefosine, an oral medication for certain cases
- Treatment duration typically ranges from 20 to 28 days
- Close monitoring during treatment due to potential medication side effects
- Surgical reconstruction may be needed for severe tissue damage
- Follow-up care to check for treatment response and possible relapse
- Protection from sandfly bites using insect repellent and protective clothing
- Avoiding outdoor activities during peak sandfly hours, typically dusk to dawn
Frequently asked questions
Cutaneous leishmaniasis affects only the skin, causing ulcers at bite sites. Mucocutaneous leishmaniasis starts with skin lesions but spreads to mucous membranes of the nose, mouth, and throat. The mucocutaneous form can cause serious tissue destruction and disfigurement. It typically develops months or years after the initial skin infection appears.
Female sandflies transmit the disease when they bite to feed on blood. The sandfly becomes infected by biting animals or people who already carry Leishmania parasites. When an infected sandfly bites you, it transfers parasites into your skin. The parasites then multiply and can eventually spread to mucous membranes.
This form of leishmaniasis occurs primarily in Central and South America. Countries with higher rates include Brazil, Peru, Bolivia, and Colombia. The disease is found in forested and rural areas where infected sandflies live. Travelers to these regions should take precautions to avoid sandfly bites.
Skin lesions typically appear within weeks to months after the bite. The spread to mucous membranes can take much longer, sometimes years. This delay makes it important to report any travel history to endemic areas. Even old skin scars can be followed by mucous membrane disease later.
Yes, the infection can be cured with proper antiparasitic treatment. Early treatment is important to prevent tissue damage and disfigurement. Treatment typically lasts 20 to 28 days with close medical supervision. Some patients may need additional treatment if the infection does not fully respond.
No, you cannot catch leishmaniasis directly from another person. The disease requires transmission through an infected sandfly bite. You cannot get it through casual contact, sharing food, or being near someone with the infection. Sandflies must be present for the disease to spread.
Untreated mucocutaneous leishmaniasis leads to progressive destruction of nasal, oral, and throat tissues. This can cause severe disfigurement of the face and nose. Breathing and swallowing can become difficult. Secondary bacterial infections may develop in damaged tissues, creating additional health risks.
Use insect repellent containing DEET on exposed skin when in endemic areas. Wear long sleeves and pants, especially during dusk and nighttime hours when sandflies are active. Sleep under bed nets treated with insecticide. Avoid outdoor activities in forested areas during peak sandfly feeding times.
Doctors can test for Leishmania antibodies in your blood, such as Leishmania Ab IgG. Elevated antibody levels suggest exposure to the parasite. However, specialized testing and tissue samples are usually needed for definitive diagnosis. Blood tests alone cannot confirm the disease but support clinical findings.
Anyone with unexplained skin sores or mucous membrane lesions after travel to endemic areas should see a doctor. People with a history of cutaneous leishmaniasis should watch for symptoms in the nose, mouth, or throat. Healthcare providers may recommend testing based on your symptoms and travel history. Early evaluation improves treatment outcomes.